A scientist at Cincinnati Children's who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the ...

GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences. Trispecific TCE targeting T cells ...

Positive high-level results from a planned interim analysis of the DeLLphi-305 Phase III trial showed Imfinzi (durvalumab) plus Amgen's Imdelltra® ...

A scientist at Cincinnati Children's who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the ...

Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantationRound was led by NBank ...

Engineering admissions in Maharashtra have climbed by 15,000 this year, with 181,927 students securing spots across 387 ...

TwoStep Therapeutics, a biotechnology company developing multi-specific targeted therapies for solid tumors, today announced an oversubscribed $62.5 million Series A financing and clearance by the U.S ...

Demon Slayer: Infinity Castle streams on Netflix US starting September 28, 2026. Netflix confirmed the date on September 13.

Long-term humoral immunity relies on long-lived plasma cells in the bone marrow (BM). However, the processes governing plasma ...

When Samsung applied the 'Ultra' suffix to its Galaxy S series, it carried a clear promise that you are getting the biggest ...

During a primary immune response, B cells can undergo isotype switching from an immunoglobulin M (IgM) B cell receptor (BCR) ...

Men are spending more on their healthcare, with a growing group of ASX stocks tapping into the boom. ... Read More The post ...